+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Artificial Pancreas Device System Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4825569
  • Report
  • July 2019
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Animas Corporation
  • Beta Bionics
  • Bigfoot Biomedical
  • Defymed
  • Insulet Corporation
  • Johnson & Johnson
  • MORE
The report on the global artificial pancreas device system market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global artificial pancreas device system market to grow with a CAGR of 15.5% over the forecast period from 2019-2025. The study on artificial pancreas device system market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on artificial pancreas device system market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global artificial pancreas device system market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global artificial pancreas device system market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • Increasing prevalence of diabetes globally
  • More benefits of artificial pancreas device system over continuous glucose monitors (CGMs) and insulin pumps
2) Restraints
  • Low effectivity of the devices in case of sport persons
3) Opportunities
  • Rising dependency of insulin for type ii diabetes can provide good opportunities for the growth of the market
Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global artificial pancreas device system market is segmented on the basis of device type, treatment type, and end user.

The Global Artificial Pancreas Device System Market by Device Type
  • Control - to - Range (CTR) System
  • Threshold Suspended Device System
  • Control - to - Target (CTT) System
The Global Artificial Pancreas Device System Market by Treatment Type
  • Bi-hormonal
  • Insulin Only
  • Hybrid
The Global Artificial Pancreas Device System Market by End User
  • Hospitals
  • Research Institute
  • Other End User
Company Profiles
The companies covered in the report include
  • Bigfoot Biomedical
  • Johnson & Johnson
  • Medtronic plc
  • TypeZero Technologies
  • Semma Therapeutics
  • Insulet Corporation
  • Beta Bionics
  • Defymed
  • Animas Corporation
  • Tandem Diabetes Care
  • Other companies
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the artificial pancreas device system market.
2. Complete coverage of all the segments in the artificial pancreas device system market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global artificial pancreas device system market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Animas Corporation
  • Beta Bionics
  • Bigfoot Biomedical
  • Defymed
  • Insulet Corporation
  • Johnson & Johnson
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Artificial Pancreas Device System Market Highlights
2.2. Artificial Pancreas Device System Market Projection
2.3. Artificial Pancreas Device System Market Regional Highlights

3. Global Artificial Pancreas Device System Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Device Type
3.4.2. Growth Matrix Analysis by Treatment Type
3.4.3. Growth Matrix Analysis by End User
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Artificial Pancreas Device System Market

4. Artificial Pancreas Device System Market Macro Indicator Analysis

5. Global Artificial Pancreas Device System Market by Device Type
5.1. Control - to - Range (CTR) System
5.2. Threshold Suspended Device System
5.3. Control - to - Target (CTT) System

6. Global Artificial Pancreas Device System Market by Treatment Type
6.1. Bi-hormonal
6.2. Insulin Only
6.3. Hybrid

7. Global Artificial Pancreas Device System Market by End User
7.1. Hospitals
7.2. Research Institute
7.3. Other End User

8. Global Artificial Pancreas Device System Market by Region 2019-2025
8.1. North America
8.1.1. North America Artificial Pancreas Device System Market by Device Type
8.1.2. North America Artificial Pancreas Device System Market by Treatment Type
8.1.3. North America Artificial Pancreas Device System Market by End User
8.1.4. North America Artificial Pancreas Device System Market by Country
8.2. Europe
8.2.1. Europe Artificial Pancreas Device System Market by Device Type
8.2.2. Europe Artificial Pancreas Device System Market by Treatment Type
8.2.3. Europe Artificial Pancreas Device System Market by End User
8.2.4. Europe Artificial Pancreas Device System Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Artificial Pancreas Device System Market by Device Type
8.3.2. Asia-Pacific Artificial Pancreas Device System Market by Treatment Type
8.3.3. Asia-Pacific Artificial Pancreas Device System Market by End User
8.3.4. Asia-Pacific Artificial Pancreas Device System Market by Country
8.4. RoW
8.4.1. RoW Artificial Pancreas Device System Market by Device Type
8.4.2. RoW Artificial Pancreas Device System Market by Treatment Type
8.4.3. RoW Artificial Pancreas Device System Market by End User
8.4.4. RoW Artificial Pancreas Device System Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Artificial Pancreas Device System Market
9.2. Companies Profiles
9.2.1. Bigfoot Biomedical
9.2.2. Johnson & Johnson
9.2.3. Medtronic plc
9.2.4. TypeZero Technologies
9.2.5. Semma Therapeutics
9.2.6. Insulet Corporation
9.2.7. Beta Bionics
9.2.8. Defymed
9.2.9. Animas Corporation
9.2.10. Tandem Diabetes Care
9.2.11. Other companies

10. Appendix
10.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Bigfoot Biomedical
  • Johnson & Johnson
  • Medtronic plc
  • TypeZero Technologies
  • Semma Therapeutics
  • Insulet Corporation
  • Beta Bionics
  • Defymed
  • Animas Corporation
  • Tandem Diabetes Care
Note: Product cover images may vary from those shown
Adroll
adroll